TT
Therapeutic Areas
Ting Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Otoprotectant for Aminoglycoside-Induced Hearing Loss | Prevention of chemotherapy-induced ototoxicity | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Otoprotectant for Aminoglycoside-Induced Hearing Loss | Prevention of chemotherapy-induced ototoxicity | Pre-clinical |